Abstract:Cleidocranial dysplasia (CCD) is an autosomal dominant inheritable skeletal disorder characterized by cranial dysplasia, clavicle hypoplasia, and dental abnormalities. Mutations involving Runt-related transcription factor 2 (RUNX2) are currently the only known molecular etiology for CCD but are not identified in all CCD patients. No RUNX2 abnormality can be detected in about 20-30% of patients, and the molecular cause remains unknown. The present study includes a family case with typical features of CCD. RUNX2 mutation was first screened by sequencing analysis, and no mutation was detected. Copy number alterations of the RUNX2 gene were then measured by quantitative PCR and multiplex ligation-dependent probe amplification (MLPA). No copy number variation in RUNX2 could be detected. We performed whole-exome sequencing (WES) to identify the underlying genetic mutations. Unexpectedly, no abnormalities could be detected in genes related to the RUNX2 signaling pathway. Therefore, it was supposed that other new unknown gene variations might contribute to the CCD phenotype. We focused on Immunoglobulin superfamily member 10 (IGSF10), a gene related to bone development. An IGSF10 frameshift mutation (c.6001_6002delCT, p.Leu2001Valfs*24) was detected by WES. Sanger sequencing verified that this mutation was only detected in the patient and her affected mother but not in her unaffected father. Bioinformatics studies demonstrated that this mutation could change the 3D structure of the IGSF10 protein and severely damage its function. In addition, alkaline phosphatase (ALP) activity and the ability to form mineralized nodules were inhibited by IGSF10 knockdown compared with normal controls. The expression of bone sialoprotein (BSP) was significantly reduced by IGSF10 knockdown, but not that of other osteogenic markers. Our results provide new genetic evidence that IGSF10 mutation might contribute to CCD.

Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome.

Mutations in the RUNX2 Gene in Chinese Patients with Cleidocranial Dysplasia.

Effect of Cleidocranial Dysplasia‐related Novel Mutation of RUNX2 on Characteristics of Dental Pulp Cells and Tooth Development

Clinical Spectrum of Cleidocranial Dysplasia in a Family with Twins

Mutation Analysis of the RUNX2 Gene in a Family with Cleidocranial Dysplasia

A Novel RUNX2 Mutation in Cleidocranial Dysplasia Patients.

Combined Orthodontic-Surgical Sequential Treatment of Cleidocranial Dysplasia

Clinical Features and Diagnosis of Cleidocranial Dysplasia

Eye dose monitoring of PET/CT workers.

Genome sequencing identified a novel exonic microdeletion in the RUNX2 gene that causes cleidocranial dysplasia

Dynamical clustering and a mechanism for raft-like structures in a model lipid membrane.

Mutations in the RUNX2 gene in a patient with Cleidocranial Dysplasia

Prevalence of cholelithiasis in a Turkish population sample of postmenopausal women.

A novel single-base deletion of the RUNX Family Transcription Factor 2 gene associated with cleidocranial dysplasia

Cleidocranial dysplasia: Clinical, endocrinologic and molecular findings in 15 patients from 11 families

Abnormal bone remodeling activity of dental follicle cells from a cleidocranial dysplasia patient.

Abnormal bone remodelling activity of dental follicle cells from a cleidocranial dysplasia patient

An Exploration of Mutagenesis in a Family with Cleidocranial Dysplasia without RUNX2 Mutation

Analysis of Novel RUNX2 Mutations in Chinese Patients with Cleidocranial Dysplasia

Mutational Analysis of Runx2 Gene in Chinese Patients with Cleidocranial Dysplasia

Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia.